Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PETER LIM

NPI
1407891534
CMS profile
18853
Location
RENO, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$80,798.01

115 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
INTUITIVE SURGICAL, INC. $80,411.71 109
Eisai Inc. $144.72 3
GlaxoSmithKline, LLC. $118.29 1
SEAGEN INC. $99.95 1
Sumitomo Pharma America, Inc. $23.34 1

Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PETER LIM

NPI 1407891534 · CMS profile ID 18853

RENO, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1407891534?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PETER LIM, NPI 1407891534, CMS profile ID 18853. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1407891534?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). PETER LIM, NPI 1407891534, CMS profile ID 18853. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1407891534?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
PETER LIM, NPI 1407891534, CMS profile ID 18853, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1407891534?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

115 matching records · $80,798.01 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 115 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 115.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
INTUITIVE SURGICAL, INC. $19.0007/28/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236519046 CMS
SEAGEN INC. $99.9507/28/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1229393768 CMS
INTUITIVE SURGICAL, INC. $82.3207/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236519060 CMS
INTUITIVE SURGICAL, INC. $300.0006/25/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1236518936 CMS
INTUITIVE SURGICAL, INC. $4,000.0006/25/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1236518972 CMS
INTUITIVE SURGICAL, INC. $137.9006/23/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236518904 CMS
INTUITIVE SURGICAL, INC. $95.6506/23/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236519038 CMS
INTUITIVE SURGICAL, INC. $28.0006/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236518946 CMS
INTUITIVE SURGICAL, INC. $30.0006/20/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236518990 CMS
INTUITIVE SURGICAL, INC. $306.3706/20/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236518996 CMS
Eisai Inc. $13.3606/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244504996 CMS
INTUITIVE SURGICAL, INC. $150.0006/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236518926 CMS
INTUITIVE SURGICAL, INC. $4,000.0006/18/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1236519028 CMS
INTUITIVE SURGICAL, INC. $500.0006/18/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1236519034 CMS
INTUITIVE SURGICAL, INC. $1,500.0006/13/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1236518956 CMS
INTUITIVE SURGICAL, INC. $1,500.0006/13/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1236519010 CMS
INTUITIVE SURGICAL, INC. $137.9006/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236518890 CMS
INTUITIVE SURGICAL, INC. $560.6306/11/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236518944 CMS
INTUITIVE SURGICAL, INC. $108.0006/11/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236519078 CMS
INTUITIVE SURGICAL, INC. $30.0006/07/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236519074 CMS
INTUITIVE SURGICAL, INC. $351.9306/05/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236519064 CMS
INTUITIVE SURGICAL, INC. $30.0006/04/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236519030 CMS
INTUITIVE SURGICAL, INC. $411.9706/03/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236518920 CMS
INTUITIVE SURGICAL, INC. $351.9306/03/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236518934 CMS
INTUITIVE SURGICAL, INC. $30.0006/03/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236519004 CMS
INTUITIVE SURGICAL, INC. $19.0006/02/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236518896 CMS
INTUITIVE SURGICAL, INC. $30.0005/27/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236518988 CMS
INTUITIVE SURGICAL, INC. $137.9005/23/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236519008 CMS
INTUITIVE SURGICAL, INC. $4,000.0005/21/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1236518900 CMS
INTUITIVE SURGICAL, INC. $300.0005/21/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1236518966 CMS
INTUITIVE SURGICAL, INC. $28.0005/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236519026 CMS
INTUITIVE SURGICAL, INC. $351.9305/15/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236519022 CMS
INTUITIVE SURGICAL, INC. $4,000.0005/14/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1236518932 CMS
INTUITIVE SURGICAL, INC. $300.0005/14/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1236518964 CMS
INTUITIVE SURGICAL, INC. $19.0005/13/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236518922 CMS
INTUITIVE SURGICAL, INC. $249.7005/13/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236518960 CMS
INTUITIVE SURGICAL, INC. $259.7205/13/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236519036 CMS
INTUITIVE SURGICAL, INC. $30.0005/13/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236519042 CMS
INTUITIVE SURGICAL, INC. $28.0005/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236518878 CMS
INTUITIVE SURGICAL, INC. $269.5405/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236518950 CMS
INTUITIVE SURGICAL, INC. $30.0005/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236518938 CMS
INTUITIVE SURGICAL, INC. $2,500.0004/16/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1236519018 CMS
INTUITIVE SURGICAL, INC. $300.0004/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236519062 CMS
INTUITIVE SURGICAL, INC. $134.1803/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236519040 CMS
Eisai Inc. $123.8303/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244505000 CMS
INTUITIVE SURGICAL, INC. $1,500.0003/12/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1236518868 CMS
INTUITIVE SURGICAL, INC. $0.0102/27/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1236519054 CMS
INTUITIVE SURGICAL, INC. $4,000.0002/26/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1236518942 CMS
INTUITIVE SURGICAL, INC. $4,000.0002/26/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1236518978 CMS
INTUITIVE SURGICAL, INC. $150.0002/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236519000 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $90,984.78 102
PY2020 $43,737.01 62
PY2021 $18,466.23 47
PY2022 $97,493.98 114
PY2023 $75,603.60 79
PY2024 $33,595.31 56
PY2025 $80,798.01 115

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $118,397.61 17
PY2024 Principal investigator $301,708.15 17
PY2023 Principal investigator $248,199.86 11
PY2022 Principal investigator $24,813.37 3
PY2021 Principal investigator $181,025.00 26
PY2020 Principal investigator $112,679.25 8
PY2019 Principal investigator $187,811.00 11

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

17 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $14,650.53 12/04/2025 Non-covered Recipient Entity
CENTER OF HOPE
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA) No dispute reported 06/30/2026 1202527166
Principal investigator 1 Karyopharm Therapeutics Inc. $27,500.00 11/06/2025 Non-covered Recipient Entity
Center of Hope
A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma No dispute reported 06/30/2026 1246662874
Principal investigator 1 ABBVIE INC. $19,684.00 09/16/2025 Non-covered Recipient Entity
PETER C LIM MD LTD
Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FR) Expressing, Platinum-sensitive Epithelial Ovarian Cancer No dispute reported 06/30/2026 1202511096
Principal investigator 1 ABBVIE INC. $6,210.00 09/16/2025 Non-covered Recipient Entity
PETER C LIM MD LTD
Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FR) Expressing, Platinum-sensitive Epithelial Ovarian Cancer No dispute reported 06/30/2026 1202511098
Principal investigator 1 ABBVIE INC. $5,680.00 09/03/2025 Non-covered Recipient Entity
CENTER OF HOPE
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA) No dispute reported 06/30/2026 1202508360
Principal investigator 1 Karyopharm Therapeutics Inc. $1,645.32 08/27/2025 Non-covered Recipient Entity
Center of Hope
A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma No dispute reported 06/30/2026 1246662856
Principal investigator 1 Karyopharm Therapeutics Inc. $1,534.68 08/27/2025 Non-covered Recipient Entity
Center of Hope
A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma No dispute reported 06/30/2026 1246662860
Principal investigator 1 Karyopharm Therapeutics Inc. $1,645.32 08/27/2025 Non-covered Recipient Entity
Center of Hope
A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma No dispute reported 06/30/2026 1246662862
Principal investigator 1 Karyopharm Therapeutics Inc. $2,056.32 08/27/2025 Non-covered Recipient Entity
Center of Hope
A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma No dispute reported 06/30/2026 1246662866
Principal investigator 1 Karyopharm Therapeutics Inc. $1,645.32 08/27/2025 Non-covered Recipient Entity
Center of Hope
A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma No dispute reported 06/30/2026 1246662872
Principal investigator 1 Karyopharm Therapeutics Inc. $1,829.52 07/29/2025 Non-covered Recipient Entity
Center of Hope
A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma No dispute reported 06/30/2026 1246662854
Principal investigator 1 Genmab U.S., Inc. $27,500.00 07/10/2025 Non-covered Recipient Entity
CENTER OF HOPE
A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) Versus Treatment of Investigator's Choice (IC) in Patients With Platinum Resistant Ovarian Cancer No dispute reported 06/30/2026 1235930032
Principal investigator 1 Karyopharm Therapeutics Inc. $1,363.32 01/23/2025 Non-covered Recipient Entity
Center of Hope
A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma No dispute reported 06/30/2026 1246662852
Principal investigator 1 Karyopharm Therapeutics Inc. $1,363.32 01/23/2025 Non-covered Recipient Entity
Center of Hope
A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma No dispute reported 06/30/2026 1246662858
Principal investigator 1 Karyopharm Therapeutics Inc. $1,363.32 01/23/2025 Non-covered Recipient Entity
Center of Hope
A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma No dispute reported 06/30/2026 1246662864
Principal investigator 1 Karyopharm Therapeutics Inc. $1,363.32 01/23/2025 Non-covered Recipient Entity
Center of Hope
A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma No dispute reported 06/30/2026 1246662868
Principal investigator 1 Karyopharm Therapeutics Inc. $1,363.32 01/23/2025 Non-covered Recipient Entity
Center of Hope
A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma No dispute reported 06/30/2026 1246662870